Fulcrum Therapeutics, Inc. — Investor Relations & Filings
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small molecule therapies for genetically defined diseases with high unmet medical needs. The company utilizes a proprietary technology platform to identify drug targets that can modulate gene expression, aiming to treat the root cause of a disease. This approach focuses on regulating genes that are incorrectly expressed. Fulcrum's pipeline is concentrated on creating disease-modifying treatments for rare conditions, with key programs in sickle cell disease and facioscapulohumeral muscular dystrophy (FSHD).
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 12974322 | 8-K | 2025-08-28 | English | ||
| 12974323 | Major Shareholding Notification 2025 | 2025-08-12 | English | ||
| 12974324 | 10-Q | 2025-07-29 | English | ||
| 12974325 | 8-K | 2025-07-29 | English | ||
| 12974326 | 4 | 2025-06-30 | English | ||
| 12974327 | 4 | 2025-06-30 | English | ||
| 12974330 | 4 | 2025-06-30 | English | ||
| 12974332 | 4 | 2025-06-30 | English | ||
| 12974329 | 4 | 2025-06-30 | English | ||
| 12974333 | 4 | 2025-06-30 | English | ||
| 12974334 | 4 | 2025-06-30 | English | ||
| 12974336 | 4 | 2025-06-30 | English | ||
| 12974335 | 8-K | 2025-06-27 | English | ||
| 12974337 | 4 | 2025-05-09 | English | ||
| 12974339 | DEFR14A | 2025-05-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Fulcrum Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32881/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32881 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32881 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32881 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32881}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Fulcrum Therapeutics, Inc. (id: 32881)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.